C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 405/02 (2006.01) A61K 31/505 (2006.01) C07D 239/545 (2006.01) C07D 311/58 (2006.01) C07D 401/02 (2006.01) C07D 405/06 (2006.01) C07D 405/12 (2006.01)
Patent
CA 2216288
Disclosed is a hydroquinone derivative or a pharmaceutically acceptable salt thereof, the hydroquinone derivative being represented by formula (I): Image wherein R1 is a phenyl group which is unsubstituted or substituted with a substituent or substituents each independently selected from the group consisting of a halogen atom, a C1-4 alkyl group and a C1-4 alkoxy group; R2 is a hydrogen atom or a C1-4 alkyl group; each of R3 and R4 is independently a hydrogen atom or a C1-4 alkyl group; R5 is a hydrogen atom or a C1-4 alkyl group; each of R6, R7 and R8 is independently a hydrogen atom or a C1-4 alkyl group; P is a hydroxyl group; Q is a hydroxyl group, a C1-4 alkoxy group, a C1-18 acyloxy group or an oxo group; P may form together with Q an ether bond; R is a hydroxyl group, a C1-4 alkoxy group, a C1-18 acyloxy group or an oxo group, provided that when one of said Q and said R is an oxo group, the other is also an oxo group; 38 X is a single bond, an -NR10- group or a -CH2-NR10- group in which R10 is a hydrogen atom or a C1-4 alkyl group; Y is a methylene group or a carbonyl group; and dotted bonds in a six membered ring represent that said six membered ring has the maximum number of double bonds. The hydroquinone derivative or a pharmaceutically acceptable salt thereof according to the invention is useful as antiallergic agents. 39
Goto Yuso
Isobe Yoshiaki
Takahashi Osamu
Tobe Masanori
Hill & Schumacher
Japan Energy Corporation
LandOfFree
Uracilic hydroquinone derivatives as type iv allergy inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uracilic hydroquinone derivatives as type iv allergy inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uracilic hydroquinone derivatives as type iv allergy inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1407101